The initial pilot study into the use of Fenzian in mild asthma was published in the European Respiratory Journal in 2009. A further asthma pilot study into use of Fenzian in severe, unstable, asthmatics was completed in August 2011 with encouraging provisional results and was presented at the 2012 American Thoracic Society.
From the initial audit results, through scientific studies, pilot studies and clinical trials Fenzian has shown already most encouraging outcomes. There have been no negative outcomes even though there is wide variation in the studies undertaken.
See details of our published results.
“I was in so much pain I could hardly put my foot on the ground. After Fenzian treatment, I was able to teach football again.”
Ankle distortion - Kevin